RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Talecris Biotherapeutics Holdings Corp. (“Talecris”) (Nasdaq: TLCR) today announced its financial results for the three and twelve months ended December 31, 2009 and filed its 2009 Form 10-K with the U.S. Securities and Exchange Commission (SEC).